Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 19.0M | 49.3M | 23.7M | 22.4M |
| Cost of revenue | 24.2M | 60.2M | 29.9M | 29.5M |
| Gross profit | -5.2M | -10.9M | -6.2M | -7.1M |
| Operating expense | ||||
| Research & development | 11.1M | 11.6M | 12.8M | 16.6M |
| Selling general and admin | 15.0M | 15.9M | 14.6M | 17.7M |
| Other operating expenses | — | — | — | — |
| Operating income | -31.3M | -38.5M | -33.6M | -41.4M |
| Non operating interest income | ||||
| Income | 2.4M | 3.0M | 3.3M | 3.4M |
| Expense | 2.6M | 2.5M | 2.6M | 2.3M |
| Other income expense | -852K | -1.6M | -2.2M | 2.6M |
| Pretax income | -32.4M | -39.6M | -35.1M | -37.7M |
| Tax provision | 0 | 23K | 2K | 0 |
| Net income | -32.4M | -39.6M | -35.1M | -37.7M |
| Basic EPS | -1.4 | -2.2 | -2.1 | -2.1 |
| Diluted EPS | -1.4 | -2.2 | -2.1 | -2.1 |
| Basic average shares | 20.5M | 19.1M | 16.8M | 15.1M |
| Diluted average shares | 20.5M | 19.1M | 16.8M | 15.1M |
| EBITDA | -18.3M | -25.7M | -23.3M | -25.8M |
| Net income from continuing op. | -32.4M | -39.6M | -35.1M | -37.7M |
| Minority interests | 4.1M | -1.8M | 2.5M | 5.5M |
| Preferred stock dividends | — | — | — | — |